| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.687 | 0.002 | 0.687 | Neurokinin antagonist | 0.686 0.002 DBMET01379 0.617 0.003 DBMET01380 | ||
| 0.677 | 0.016 | 0.719 | Analgesic | 0.658 0.018 DBMET01379 0.719 0.012 DBMET01380 | DBMET01380 | |
| 0.663 | 0.002 | 0.663 | Neurokinin 1 antagonist | 0.662 0.002 DBMET01379 0.59 0.002 DBMET01380 | ||
| 0.518 | 0.003 | 0.518 | Substance P antagonist | 0.515 0.003 DBMET01379 0.445 0.003 DBMET01380 | ||
| 0.475 | 0.046 | 0.505 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.505 0.031 DBMET01379 0.393 0.107 DBMET01380 | DBMET01379 | |
| 0.344 | 0.003 | 0.344 | Neurokinin 3 antagonist | 0.336 0.003 DBMET01379 0.286 0.003 DBMET01380 | ||
| 0.393 | 0.063 | 0.407 | MAP kinase kinase 6 inhibitor | 0.407 0.054 DBMET01379 0.321 0.116 DBMET01380 | DBMET01379 | |
| 0.33 | 0.006 | 0.371 | Vanilloid antagonist | 0.325 0.006 DBMET01379 0.371 0.005 DBMET01380 | DBMET01380 | |
| 0.292 | 0.038 | 0.292 | EphB2 antagonist | 0.272 0.046 DBMET01379 0.198 0.089 DBMET01380 | ||
| 0.252 | 0.057 | 0.252 | Anticonvulsant | 0.2 0.083 DBMET01379 0.216 0.072 DBMET01380 | ||
| 0.203 | 0.009 | 0.203 | Vanilloid 1 antagonist | 0.188 0.01 DBMET01379 0.125 0.019 DBMET01380 | ||
| 0.195 | 0.008 | 0.195 | Interleukin 2 antagonist | 0.18 0.01 DBMET01379 0.15 0.018 DBMET01380 | ||
| 0.296 | 0.113 | 0.346 | Toll-Like receptor 7 agonist | 0.317 0.1 DBMET01379 0.346 0.084 DBMET01380 | DBMET01380 | |
| 0.198 | 0.017 | 0.198 | Calcium channel N-type blocker | 0.161 0.031 DBMET01379 0.099 0.097 DBMET01380 | ||
| 0.286 | 0.12 | 0.335 | Toll-Like receptor agonist | 0.306 0.107 DBMET01379 0.335 0.09 DBMET01380 | DBMET01380 | |
| 0.201 | 0.036 | 0.212 | Cytokine production inhibitor | 0.212 0.033 DBMET01379 0.111 0.099 DBMET01380 | DBMET01379 | |
| 0.173 | 0.023 | 0.173 | Ca(v)2.2 blocker | 0.165 0.025 DBMET01379 0.111 0.042 DBMET01380 | ||
| 0.158 | 0.02 | 0.158 | Hedgehog signaling inhibitor | 0.151 0.023 DBMET01379 0.096 0.071 DBMET01380 | ||
| 0.168 | 0.045 | 0.168 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.163 0.052 DBMET01379 0.144 0.085 DBMET01380 | ||
| 0.2 | 0.093 | 0.2 | Potassium channel blocker | 0.176 0.11 DBMET01379 | ||
| 0.218 | 0.119 | 0.235 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.235 0.087 DBMET01379 0.218 0.12 DBMET01380 | DBMET01379 | |
| 0.122 | 0.035 | 0.145 | Protein kinase C delta inhibitor | 0.145 0.024 DBMET01379 | DBMET01379 | |
| 0.103 | 0.026 | 0.105 | Syk tyrosine kinase inhibitor | 0.105 0.026 DBMET01379 0.085 0.037 DBMET01380 | DBMET01379 | |
| 0.14 | 0.071 | 0.14 | Protein-tyrosine kinase Lyn inhibitor | 0.13 0.077 DBMET01379 | ||
| 0.118 | 0.059 | 0.118 | Calcium channel (voltage-sensitive) blocker | 0.101 0.082 DBMET01379 | ||
| 0.099 | 0.042 | 0.099 | Bcr-Abl kinase inhibitor | |||
| 0.173 | 0.118 | 0.173 | Potassium channel (Voltage-sensitive) blocker | 0.155 0.133 DBMET01379 | ||
| 0.112 | 0.06 | 0.112 | Granulocyte macrophage colony stimulating factor antagonist | 0.098 0.074 DBMET01379 | ||
| 0.088 | 0.041 | 0.088 | Fibroblast growth factor 3 antagonist | 0.079 0.052 DBMET01379 | ||
| 0.064 | 0.017 | 0.064 | Smo receptor antagonist | 0.047 0.025 DBMET01379 | ||
| 0.054 | 0.014 | 0.054 | Nerve growth factor antagonist | 0.039 0.037 DBMET01379 | ||
| 0.119 | 0.083 | 0.119 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.116 0.086 DBMET01379 | ||
| 0.141 | 0.109 | 0.141 | TRKC antagonist | 0.127 0.124 DBMET01379 | ||
| 0.094 | 0.064 | 0.098 | Interleukin 12 antagonist | 0.098 0.056 DBMET01379 0.091 0.07 DBMET01380 | DBMET01379 | |
| 0.057 | 0.028 | 0.059 | Diacylglycerol O-acyltransferase inhibitor | 0.059 0.026 DBMET01379 | DBMET01379 | |
| 0.124 | 0.097 | 0.127 | CC chemokine 6 receptor antagonist | 0.127 0.081 DBMET01380 | DBMET01380 | |
| 0.154 | 0.127 | 0.154 | HERG channel blocker | |||
| 0.061 | 0.036 | 0.065 | Protein kinase C theta inhibitor | 0.065 0.029 DBMET01379 | DBMET01379 | |
| 0.032 | 0.007 | 0.032 | Apolipoprotein B inhibitor | |||
| 0.03 | 0.006 | 0.03 | Apolipoprotein B-100 inhibitor | 0.018 0.012 DBMET01379 | ||
| 0.057 | 0.034 | 0.06 | Protein kinase C epsilon inhibitor | 0.06 0.03 DBMET01379 | DBMET01379 | |
| 0.068 | 0.051 | 0.068 | Glutamate (mGluR group I) antagonist | 0.064 0.058 DBMET01379 | ||
| 0.113 | 0.097 | 0.113 | Toll-Like receptor antagonist | |||
| 0.099 | 0.086 | 0.099 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.099 | 0.086 | 0.099 | Abl kinase inhibitor | |||
| 0.035 | 0.023 | 0.035 | Gonadotropin-releasing hormone receptor antagonist | 0.035 0.023 DBMET01379 | ||
| 0.03 | 0.019 | 0.031 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.031 0.018 DBMET01379 | DBMET01379 | |
| 0.019 | 0.008 | 0.019 | Microsomal triglyceride transfer protein inhibitor | 0.015 0.011 DBMET01379 | ||
| 0.081 | 0.071 | 0.088 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.088 0.064 DBMET01379 | DBMET01379 | |
| 0.055 | 0.046 | 0.055 | Calcium channel T-type blocker | |||
| 0.176 | 0.168 | 0.177 | Neuropeptide Y2 antagonist | 0.177 0.166 DBMET01379 | DBMET01379 | |
| 0.06 | 0.052 | 0.06 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.108 | 0.101 | 0.108 | Toll-Like receptor 9 antagonist | |||
| 0.078 | 0.071 | 0.078 | Transforming growth factor beta 3 antagonist | 0.078 0.073 DBMET01379 | ||
| 0.056 | 0.049 | 0.056 | TRPA1 antagonist | |||
| 0.068 | 0.064 | 0.068 | Glutamate (mGluR) antagonist | |||
| 0.063 | 0.061 | 0.07 | Raf kinase inhibitor | 0.07 0.055 DBMET01379 | DBMET01379 | |
| 0.06 | 0.061 | 0.075 | Protein kinase C alpha inhibitor | 0.075 0.039 DBMET01379 | DBMET01379 | |
| 0.046 | 0.057 | 0.052 | Raf kinase C inhibitor | 0.052 0.05 DBMET01379 | DBMET01379 | |
| 0.179 | 0.197 | 0.185 | MAP kinase kinase 3 inhibitor | 0.185 0.171 DBMET01379 | DBMET01379 | |
| 0.135 | 0.154 | 0.155 | Focal adhesion kinase 2 inhibitor | 0.155 0.122 DBMET01379 | DBMET01379 | |
| 0.067 | 0.093 | 0.091 | GABA A receptor agonist | 0.091 0.046 DBMET01380 | DBMET01380 | |
| 0.055 | 0.084 | 0.068 | Nav1.8 sodium channel blocker | 0.068 0.058 DBMET01379 | DBMET01379 | |
| 0.087 | 0.118 | 0.104 | Activin receptor-like kinase 4 inhibitor | 0.104 0.077 DBMET01379 | DBMET01379 | |
| 0.078 | 0.111 | 0.107 | GABA receptor agonist | 0.107 0.069 DBMET01380 | DBMET01380 | |
| 0.064 | 0.111 | 0.096 | Protein kinase C mu inhibitor | 0.096 0.061 DBMET01379 | DBMET01379 | |
| 0.204 | 0.27 | 0.376 | Cyclophilin D inhibitor | 0.235 0.23 DBMET01379 0.376 0.105 DBMET01380 | DBMET01380 | |
| 0.102 | 0.192 | 0.12 | Death-associated protein kinase 1 inhibitor | 0.12 0.114 DBMET01379 | DBMET01379 | |
| 0.061 | 0.168 | 0.106 | Glutamate receptor antagonist | 0.106 0.09 DBMET01380 | DBMET01380 | |
| 0.094 | 0.221 | 0.163 | Hypolipemic | 0.163 0.125 DBMET01380 | DBMET01380 | |
| 0.149 | 0.277 | 0.223 | Antiobesity | 0.223 0.184 DBMET01379 0.223 0.183 DBMET01380 | DBMET01380 | |
| 0.087 | 0.237 | 0.129 | Interleukin 6 antagonist | 0.129 0.127 DBMET01380 | DBMET01380 | |
| 0.031 | 0.197 | 0.069 | Protein kinase B beta inhibitor | 0.069 0.059 DBMET01380 | DBMET01380 | |
| 0.183 | 0.358 | 0.347 | Antiinflammatory | 0.347 0.175 DBMET01380 | DBMET01380 | |
| 0.008 | 0.189 | 0.049 | 5 Hydroxytryptamine 2C agonist | 0.049 0.028 DBMET01379 | DBMET01379 | |
| 0.024 | 0.235 | 0.102 | Androgen antagonist | 0.102 0.045 DBMET01380 | DBMET01380 | |
| 0.077 | 0.357 | 0.191 | Lipocortins synthesis antagonist | 0.191 0.062 DBMET01380 | DBMET01380 | |
| 0.015 | 0.297 | 0.061 | Androgen agonist | 0.061 0.04 DBMET01380 | DBMET01380 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |